22nd Century Group to Present at Institutional Investor Conference as Part of National Road Show
28 May 2014 - 9:15PM
Business Wire
22nd Century Group, Inc. (NYSE MKT:XXII) today announced that
Henry Sicignano III, President, will present at the LD MICRO
Invitational Conference at the Luxe Sunset Hotel, Los Angeles,
California, on Wednesday, June 4th, 2014 at 9:00am PDT.
22nd Century Group’s presentation at the LD Micro Invitational
Conference is part of a one-week non-deal road show. The Company
will also be conducting private meetings at the conference over the
course of the day.
Starting June 2, 2014, Joseph Pandolfino, CEO, and Henry
Sicignano, President, will visit five cities across the United
States to introduce 22nd Century Group to institutional investors,
retail brokers, and the business press. This initiative represents
the Company’s first major effort to specifically target
institutional investors since uplisting to the NYSE MKT exchange in
March 2014.
Though the Company’s shareholder base has increased from fewer
than 100 shareholders in early 2011 to more than 2,000 shareholders
today, it is clear that 22nd Century Group remains “well under the
radar” of most of Wall Street. It is management’s intention that
the Company’s road show increases awareness of 22nd Century Group’s
technology and investment potential.
About LD Micro
LD MICRO is an investment newsletter firm that focuses on
finding undervalued companies in the micro-cap space. Since 2002,
the firm has published an annual list of recommended stocks, as
well as comprehensive reports on select companies throughout the
year. The firm also hosts the LD MICRO Micro-Cap Growth Conference
for investors in December of each year. It is a non-registered
investment advisor. For more information, please call 408-457-1042
or visit www.LDmicro.com.
About 22nd Century Group, Inc.
22nd Century is a plant biotechnology company whose proprietary
technology allows for the levels of nicotine and other nicotinic
alkaloids (e.g., nornicotine, anatabine and anabasine) in the
tobacco plant to be decreased or increased through genetic
engineering and plant breeding. 22nd Century owns or is the
exclusive licensee of 116 issued patents in 78 countries plus an
additional 42 pending patent applications. Goodrich Tobacco
Company, LLC and Hercules Pharmaceuticals, LLC are wholly-owned
subsidiaries of 22nd Century. Goodrich Tobacco is focused on
commercial tobacco products and potentially less harmful
cigarettes. Hercules Pharmaceuticals is focused on X-22, a
prescription smoking cessation aid in development.
For additional information, please visit:
www.xxiicentury.com
Cautionary Note Regarding Forward-Looking Statements: This press
release contains forward-looking information, including all
statements that are not statements of historical fact regarding the
intent, belief or current expectations of 22nd Century Group, Inc.,
its directors or its officers with respect to the contents of this
press release. The words “may,” “would,” “will,” “expect,”
“estimate,” “anticipate,” “believe,” “intend” and similar
expressions and variations thereof are intended to identify
forward-looking statements. We cannot guarantee future results,
levels of activity or performance. You should not place undue
reliance on these forward-looking statements, which speak only as
of the date that they were made. These cautionary statements should
be considered with any written or oral forward-looking statements
that we may issue in the future. Except as required by applicable
law, including the securities laws of the United States, we do not
intend to update any of the forward-looking statements to conform
these statements to reflect actual results, later events or
circumstances, or to reflect the occurrence of unanticipated
events. You should carefully review and consider the various
disclosures made by us in our annual report on Form 10-K for the
fiscal year ended December 31, 2013, filed on January 30, 2014,
including the section entitled “Risk Factors,” and our other
reports filed with the U.S. Securities and Exchange Commission
which attempt to advise interested parties of the risks and factors
that may affect our business, financial condition, results of
operation and cash flows. If one or more of these risks or
uncertainties materialize, or if the underlying assumptions prove
incorrect, our actual results may vary materially from those
expected or projected.
Redington, Inc.Tom Redington, 203-222-7399
22nd Century (AMEX:XXII)
Historical Stock Chart
From Apr 2024 to May 2024
22nd Century (AMEX:XXII)
Historical Stock Chart
From May 2023 to May 2024